Latest IPOs

The Indian primary market entered 2026 on a cautious note as heightened global geopolitical tensions weighed heavily on investor sentiment. Ongoing conflicts and uncertainties — ranging from the Iran humanitarian crisis, escalating Russia–Ukraine–NATO tensions, renewed …

In an era where equitable access to quality science education remains a persistent challenge, Indian Institute of Technology Kanpur has rolled out a compelling grassroots solution: a fully equipped Science Bus that brings laboratory-based STEM …

Strong recovery, high-margin portfolio shift, and capacity-led earnings leverage underpin ₹1,955 target ICICI Securities has reaffirmed BUY rating on Tatva Chintan Pharma with a revised target price of INR 1,955 per share, up from INR …

Bombay Coated and Special Steels (BCSSL), a growing player in India’s value-added steel processing segment, has refiled its DRHP with the Securities and Exchange Board of India (SEBI) to raise INR 191 crore via an …

As Budget 2026 draws closer, industry leaders across sectors are pinning high hopes on it. Business heads and experts are looking for fresh reforms and targeted policy measures that can accelerate growth, improve affordability and …

When IPO frenzy meets reality: these were heavily chased, many were oversubscribed, and within a year several are available well below issue price. In primary markets, IPO demand is always loud. Oversubscription numbers get quoted …

Financial News Made Simple

Join Riverwood Capital and get your daily dose of the latest, most important Financial developments.

"Partner. Collaborate. Grow Together."

Scroll to Top